Cytosorbents Corporation

afternoon ladies and gentlemen and welcome to the Cytosormant Corp third quarter 2025 earnings conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, November 13th of 2025. I would now like to turn the conference over to Adana Alexander, Investor Relations Consultant. Please go ahead.

Thank you, Chloe, and good afternoon, everyone. Welcome to Sites of Sovereign's third quarter 2025 financial results and recent business highlights conference call. Joining me today from the company for the prepared remarks are Dr. Philip Chan, Chief Executive Officer, and Pete Mariani, Chief Financial Officer. Before I turn the call over to Dr. Chan, I'd like to remind listeners that during the call, management's prepared remarks may contain forward-looking statements which are subject to risks and uncertainties. Management may make additional forward-looking statements in response to your questions today. Therefore, the company claims protection under the Safe Harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual results made differ from results discussed today. The forward-looking statements we make may reflect our views and estimates as of today, November 13th, 2025, and we assume no obligation to update these projections in the future as market conditions change. During today's call, we will have an overview presentation covering the operating and financial highlights for the third quarter 2025. Following the presentation, we will open the lines and list the questions. And now, it is my pleasure to turn the call over to Dr. Philip Chan. Philip?

Thank you very much, Adana, and good afternoon, everyone.